Search

everythinglearnresearchcommunity

for

Search:↓

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Twisted hair is rare in severe anorexia nervosa, found in only 2 out of 30 patients.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Eating vegetarian, having allergies, and family history might be linked to getting gray hair early.

Darkened knuckles can be an early sign of insulin resistance.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Genetic factors affecting skin health and body weight may increase the risk of dermatophytosis.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Men with severe balding have a higher risk of getting very sick from COVID-19.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The normal human prostate does not significantly affect blood DHT levels.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.